A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

NCT00414518 ·Status: COMPLETED ·Phase: NA

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

NCT04564547 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

NCT00002411 ·Status: COMPLETED ·Phase: NA

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

NCT00000940 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520 ·Status: COMPLETED ·Phase: PHASE3

TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

NCT00254046 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

NCT00082394 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients

NCT00002307 ·Status: COMPLETED ·Phase: NA

Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients

NCT00084253 ·Status: COMPLETED ·Phase: PHASE4

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection

NCT01199731 ·Status: TERMINATED ·Phase: PHASE2

A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

NCT00002155 ·Status: COMPLETED ·Phase: NA

A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)

NCT02217904 ·Status: COMPLETED ·Phase: PHASE1

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

NCT00255099 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

NCT00002403 ·Status: COMPLETED ·Phase: PHASE1

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1

NCT06630299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

NCT00000781 ·Status: COMPLETED ·Phase: PHASE2

Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)

NCT00920426 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

NCT00002451 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors

NCT00002361 ·Status: COMPLETED ·Phase: PHASE2

To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults

NCT02369146 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease

NCT00001045 ·Status: COMPLETED ·Phase: PHASE2

Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002)

NCT03188523 ·Status: COMPLETED ·Phase: PHASE1

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

NCT00050895 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily

NCT00002241 ·Status: UNKNOWN ·Phase: PHASE2

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

NCT00513513 ·Status: TERMINATED ·Phase: PHASE2